Prevalence of nosocomial infections in Covid-19 patients admitted to the intensive care unit of Imam Khomeini complex hospital in Tehran
Abstract
Background and Objectives: Nosocomial infections (NIs) are an important cause of mortality and morbidity in intensive care units (ICU). Pneumonia is the most common serious manifestation of infection in Covid-19 patients. The aim of this study was to investigate the prevalence of pneumonia in Covid-19 patients admitted to the ICU.
Materials and Methods: In this cross-sectional study, 1240 Covid-19 patients admitted for more than 48 h in the ICUs of Imam Khomeini Complex Hospital (IKCH) in Tehran for seven months in 2020 were included in the study with initial diagnosis of Covid-19 (PCR test and chest imaging). Data were collected regarding severity of the illness, primary reason for ICU admission, presence of risk factors, presence of infection, length of ICU and hospital stay, microbial type and antibiotic resistance. In this study, the pattern of antibiotic resistance was determined using the disk difusion method.
Results: In this study, 289 (23.3%) out of 1320 patients experienced NIs. 221 (76.4%) out of 289 patients had underlying diseases and the most common of which were hypertension, diabetes and heart disease, respectively. 163 patients (56.4%) were RT-PCR COVID-19 positive and 200 patients (69%) died. The majority of patients with NIs (71%) were over 55 years old. The most common type of nosocomial infection (66%) was ventilator-associated pneumonia (VAE). The most common microorganisms that cause pneumonia were Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa, respectively.
Conclusion: Pneumonia infection is high in Covid-19 patients admitted to the ICU, it needs to be planned with the diagnosis and measures related to the control and prevention of this infection.
2. Afhami S, Hadadi A, Khorami E, Seifi A, Bazaz NE. Ventilator-associated pneumonia in a teaching hospital in Tehran and use of the Iranian nosocomial infections surveillance software. East Mediterr Health J 2013; 19: 883-887.
3. Mohammadnejad E, Abbaszadeh A, Soori H, Afhami S. Prevention and control of nosocomial infections proceeding in intensive care units: a content analysis study. Acta Medica Mediterranea 2016; 32: 1295-1301.
4. Afhami S, Seifi A, Hajiabdolbaghi M, Bazaz NE, Hadadi A, Hasibi M, et al. Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of Iran. East Mediterr Health J 2019; 25: 90-97.
5. Ocran I, Tagoe DNA. Knowledge and attitude of healthcare workers and patients on healthcare associated infections in a regional hospital in Ghana. Asian Pac J Trop Dis 2014; 4: 135-139.
6. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329.
7. Scherbaum M, Kösters K, Mürbeth RE, Ngoa UA, Kremsner PG, Lell B, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect Dis 2014; 14: 124.
8. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics 2002; 109: 758-764.
9. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273.
10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
11. Nakajima K, Kato H, Yamashiro T, Izumi T, Takeuchi I, Nakajima H, et al. COVID-19 pneumonia: infection control protocol inside computed tomography suites. Jpn J Radiol 2020; 38: 391-393.
12. Larypoor M, Frsad S. Evaluation of nosocomial infections in one of hospitals of Qom ,2008. Iran J Med Microbiol 2011; 5: 7-17.
13. Esfahani BN, Basiri R, Mirhosseini SMM, Moghim S, Dolatkhah S. Nosocomial infections in intensive care unit: pattern of antibiotic-resistance in Iranian community. Adv Biomed Res 2017; 6: 54.
14. Hassanzadeh P, Motamedifar M, Hadi N. Prevalent bacterial infections in intensive care units of Shiraz university of medical sciences teaching hospitals, Shiraz, Iran. Jpn J Infect Dis 2009; 62: 249-253.
15. Luzzati R, Antozzi L, Bellocco R, Del Bravo P, Mirandola M, Procaccio F, et al. [Prevalence of nosocomial infections in intensive care units in Triveneto area Italy]. Minerva Anestesiol 2001; 67: 647-652.
16. Ponce de León-Rosales SP, Molinar-Ramos F, Domínguez-Cherit G, Rangel-Frausto MS, Vázquez-Ramos VG. Prevalence of infections in intensive care units in Mexico: a multicenter study. Crit Care Med 2000; 28: 1316-1321.
17. Orrett FA. Nosocomial infections in an intensive care unit in a private hospital. West Indian Med J 2002; 51: 21-24.
18. Etemad M, Khani Y, Hashemi-Nazari SS, Izadi N, Eshrati B, Mehrabi Y. Survival rate in patients with ICU-acquired infections and its related factors in Iran’s hospitals. BMC Public Health 2021; 21: 787.
Files | ||
Issue | Vol 13 No 6 (2021) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/ijm.v13i6.8075 | |
Keywords | ||
Pneumonia infection; COVID-19; Intensive care unit |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |